Enact Holdings Inc

ACT remains in a Stage 2 advancing regime with a medium-term bullish bias and long-term uptrend. A recent Momentum Breakout on expanding volume cleared horizontal resistance, and price is now pulling back into the rising 9EMA and 20EMA near the prior resistance zone. Despite extreme overbought conditions, the healthy Stage 2 structure and intact EMA support favor a deferred buy strategy around the EMAs upon clear acceptance above them. Patience is advised until this pullback resolves.

• ↑Adjusted operating income rose 10% YoY to $172 M ($1.21/share) in Q1 2026.
• ↑Guided ~$500 M capital returns in 2026; dividend increased 14%.
• ↓Growth factor flagged negative; new insurance written down 11% sequentially.